An N6-methyladenosine and target genes-based study on subtypes and prognosis of lung adenocarcinoma

被引:1
|
作者
Chu, Xiao [1 ]
Wang, Weiqing [1 ]
Sun, Zhaoyun [1 ]
Bao, Feichao [2 ]
Feng, Liang [1 ]
机构
[1] Fudan Univ, Peoples Hosp Shanghai 5, Dept Thorac Surg, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Thorac Surg, Affiliated Chest Hosp, Shanghai, Peoples R China
关键词
N-6-methyladenosine (m(6)A); consensus clustering; prognostic score; immune cells; nomogram; TUMOR; EXPRESSION; CELLS; E2F7;
D O I
10.3934/mbe.2022013
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: Lung adenocarcinoma (LUAD) is a highly lethal subtype of primary lung cancer with a poor prognosis. N6-methyladenosine (m(6)A), the most predominant form of RNA modification, regulates biological processes and has critical prognostic implications for LUAD. Our study aimed to mine potential target genes of m(6)A regulators to explore their biological significance in subtyping LUAD and predicting survival. Methods: Using gene expression data from TCGA database, candidate target genes of m(6)A were predicted from differentially expressed genes (DEGs) in tumor based on M(6)A2 Target database. The survival-related target DEGs identified by Cox-regression analysis was used for consensus clustering analysis to subtype LUAD. Uni-and multi-variable Cox regression analysis and LASSO Cox-PH regression analysis were used to select the optimal prognostic genes for constructing prognostic score (PS) model. Nomogram encompassing PS score and independent prognostic factors was built to predict 3-year and 5-year survival probability. Results: We obtained 2429 DEGs in tumor tissue, within which, 1267 were predicted to m(6)A target genes. A prognostic m(6)A-DEGs network of 224 survival-related target DEGs was established. We classified LUAD into 2 subtypes, which were significantly different in OS time, clinicopathological characteristics, and fractions of 12 immune cell types. A PS model of five genes (C1QTNF6, THSD1, GRIK2, E2F7 and SLCO1B3) successfully split the training set or an independent GEO dataset into two subgroups with significantly different OS time (p < 0.001, AUC = 0.723; p = 0.017, AUC = 0.705).A nomogram model combining PS status, pathologic stage, and recurrence was built, showing good performance in predicting 3-year and 5-year survival probability (C-index = 0.708, 0.723, p-value = 0). Conclusion: Using candidate m(6)A target genes, we obtained two molecular subtypes and designed a reliable five-gene PS score model for survival prediction in LUAD.
引用
收藏
页码:253 / 270
页数:18
相关论文
共 50 条
  • [41] Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma
    Jinfang Liu
    Zijian Zhou
    Ling Ma
    Chujun Li
    Yu Lin
    Ting Yu
    Ji-Fu Wei
    Lingjun Zhu
    Gang Yao
    Cancer Cell International, 21
  • [42] Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma
    Liu, Yong
    Li, Guangbing
    Yang, Yang
    Lu, Ziwen
    Wang, Tao
    Wang, Xiaoyu
    Liu, Jun
    FRONTIERS IN GENETICS, 2022, 12
  • [43] N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma
    Hao Xu
    Lu Yin
    Qianhui Xu
    Jingjing Xiang
    Rujun Xu
    Cancer Cell International, 22
  • [44] N6-Methyladenosine Promotes Translation of VEGFA to Accelerate Angiogenesis in Lung Cancer
    Zhang, Haisheng
    Zhou, Jiawang
    Li, Jiexin
    Wang, Zhaotong
    Chen, Zhuojia
    Lv, Ziyan
    Ge, Lichen
    Xie, Guoyou
    Deng, Guoming
    Rui, Yalan
    Huang, Hongbing
    Chen, Likun
    Wang, Hongsheng
    CANCER RESEARCH, 2023, 83 (13) : 2208 - 2225
  • [45] Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma
    Liu, Jinfang
    Zhou, Zijian
    Ma, Ling
    Li, Chujun
    Lin, Yu
    Yu, Ting
    Wei, Ji-Fu
    Zhu, Lingjun
    Yao, Gang
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [46] Gene Signatures and Prognostic Values of N6-Methyladenosine Related Genes in Ovarian Cancer
    Na, Zhijing
    Fan, Ling
    Wang, Xiuxia
    FRONTIERS IN GENETICS, 2021, 12
  • [47] The N6-Methyladenosine Features of mRNA and Aberrant Expression of m6A Modified Genes in Gastric Cancer and Their Potential Impact on the Risk and Prognosis
    Sang, Liang
    Sun, Liping
    Wang, Ang
    Zhang, Han
    Yuan, Yuan
    FRONTIERS IN GENETICS, 2020, 11
  • [48] The Progression of N6-methyladenosine Study and Its Role in Neuropsychiatric Disorders
    Lei, Chunguang
    Wang, Qingzhong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
  • [49] Association of N6-methyladenosine readers' genes variation and expression level with pulmonary tuberculosis
    Li, Hong-Miao
    Tang, Fei
    Wang, Li-Jun
    Huang, Qian
    Pan, Hai-Feng
    Zhang, Tian-Ping
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [50] The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers (vol 6, 75, 2021)
    Tan, Shuzhen
    Li, Zesong
    Li, Kai
    Li, Yingqi
    Liang, Guosheng
    Tang, Zhenye
    Kang, Jianhao
    Chen, Wenqing
    Li, Minhua
    Zou, Zhilin
    Pi, Guoliang
    Zhu, Xiao
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10